MR blockade by anti-MR antibodies decreases the phagocytic and fungicidal abilities and NO production of A/J and B10.A macrophages. by Claudia Feriotti (286149)

Infection with BVDV R₂, R₃ and R₅ leads to a decrease in dead cells. by Eliana F. Castro (581093)

Pretreatment of Huh-7.5.1 cells with PF-429242 results in a robust decrease in intracellular viral RNA for all four DENV serotypes. by Anastasia Hyrina (3860455)

BH3 Peptides induces a decrease in mitochondrial membrane potential but does not engage the Permeability Transition Pore. by Emelyn H. Shroff (163459)

Founder haplotype means and 1-SDs for the three QTL mapped in both panels of DSPR RILs. by Michael A. Najarro (831657)

Revisiting the sealed heating method–V158411 decreases Chk1 nuclear immunofluorescence in HT29 cells heated in a low well volume. by Andrew J. Massey (239469)

ASO treatment suppresses the palbociclib-mediated induction of MEG3 and decrease in cell proliferation in A549 cells. by Traci L. Kruer (3342425)

PGC-1β KO mice show a specific decrease in Mfn2 expression in skeletal muscle. by Marc Liesa (35879)

Thalidomide treatment inhibits growth in RAMEC but not in RAMEC transfected with a dominant negative mutant of CUL5 (^S730ACUL5) cDNA. by Bryan Kunkler (5204327)

Dexamethasone (DEX)-induced transient <i>CPK31</i> expression caused a decrease in As(III) tolerance. by Ruijie Ji (3839032)

Geometric mean concentrations of 5 most abundant PCDD/F congeners and the sum of other congeners (A), and PCDD and PCDF TEQ (C) in different study areas during the first (1972–1986... by Matti Viluksela (321291)

A mutation in <i>dSK</i> results in decreased long-term memory 24 h after 5 h ‘extended’ training session. by Ahmad N. Abou Tayoun (326696)

Compounds decrease polyQ toxicity in a <i>pqe-1</i> independent manner in aged animals. by Cindy Voisine (30589)

Antiviral use is associated with a decrease in the rate of influenza-related complications, health care resource utilization, and costs by Chris Wallick (10131528)

TA1 results in a decreased <i>in vivo</i> inflammatory response upon allogeneic cells challenge. by Duncheng Wang (838084)

Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

“…<p>Rh4 and RMS13 cells were treated for 24 hours (A) and 48 hours (B) with different concentrations of fenretinide (0.5–1–5 µM, as indicated). …”

Image_1_Prediabetes: Adherence to Nutrition Visits Decreases HbA1c in Children and Adolescents.tiff by Sadichchha Parajuli (11716967)

Influence of ghrelin treatment (0.5 μg/g BW, twice a day, intraperitoneal (ip.)) on oxidative burst capacity of neutrophils after cecal ligation and puncture (CLP)-induced sepsis. by Daniel Siegl (717509)

Influence of ghrelin treatment (0.5 μg/g BW, twice a day, intraperitoneal (ip.)) on peritoneal cellular immune response after cecal ligation and puncture (CLP)-induced sepsis. by Daniel Siegl (717509)

Pretreatment of β-cells with recombinant CXCL12 improves viability and induces a decrease in PARP-1 activity. by Nevena Grdović (394542)